Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: An in vivo human study using susceptibility and relaxivity dynamic MRI

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 3, 2011, Pages 721-727

  Alonzi, Roberto ^a   Padhani, Anwar R ^a   Taylor, N Jane ^a   Collins, David J ^b   D'Arcy, James A ^b   Stirling, J James ^a   Saunders, Michele I ^a   Hoskin, Peter J ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Androgen deprivation; Blood flow; Hypoxia; Magnetic resonance imaging; Prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION; ANDROGEN SUPPRESSION; ANIMAL MODEL; ANTIVASCULAR; BLOOD FLOW; BLOOD OXYGENATION; BLOOD VOLUMES; DYNAMIC MRI; HORMONE TREATMENT; HUMAN PROSTATE; HUMAN PROSTATE CANCER; HUMAN STUDY; HYPOXIA; IN-VIVO; MULTIPARAMETERS; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE TUMOR; RELAXIVITY; TIME-SCALES; TRANSFER CONSTANT; TUMOR BLOOD VOLUME; TUMOR OXYGENATION; VASCULAR COLLAPSE; VASCULAR PERMEABILITY;

BLOOD; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; OXYGENATION; OXYGENATORS; PATIENT TREATMENT; RESONANCE; TUMORS;

DISEASES;

BICALUTAMIDE; DEOXYHEMOGLOBIN; GADOLINIUM PENTETATE MEGLUMINE; GOSERELIN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BLOOD OXYGEN LEVEL DEPENDENT MAGNETIC RESONANCE IMAGING; BLOOD OXYGENATION; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; CANCER ADJUVANT THERAPY; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; DRUG EFFECT; DYNAMIC RELAXIVITY BASED CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; HUMAN; HYPOXIA; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; REPRODUCIBILITY; TUMOR BLOOD FLOW;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; BLOOD VOLUME; CAPILLARY PERMEABILITY; CELL HYPOXIA; GOSERELIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NITRILES; OXYGEN; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TOSYL COMPOUNDS;

EID: 79955090686     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.02.060     Document Type: Article

References (38)

1. A.W. Fyles, M. Milosevic, and R. Wong Oxygenation predicts radiation response and survival in patients with cervix cancer Radiother Oncol 48 1998 149 156 (Pubitemid 28423786)
2. B. Movsas, J.D. Chapman, and A.L. Hanlon Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings Urology 60 2002 634 639 (Pubitemid 35246449)
3. M. Nordsmark, M. Overgaard, and J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 1996 31 39 (Pubitemid 26396294)
4. R. Vergis, C.M. Corbishley, and A.R. Norman Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: A retrospective analysis of two randomised radiotherapy trials and one surgical cohort study Lancet Oncol 9 2008 342 351
5. M.W. Dewhirst, Y. Cao, and B. Moeller Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat Rev Cancer 8 2008 425 437 (Pubitemid 351744964)
6. E. Lekas, M. Johansson, and A. Widmark Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration Urol Res 25 1997 309 314 (Pubitemid 27461601)
7. A. Shabsigh, D.T. Chang, and D.F. Heitjan Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival Prostate 36 1998 201 206 (Pubitemid 28341133)
8. A. de la Taille, M.W. Chen, and A. Shabsigh Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland Prostate 40 1999 89 96 (Pubitemid 29304699)
9. O.R. Hayek, A. Shabsigh, and S.A. Kaplan Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity J Urol 162 1999 1527 1531 (Pubitemid 29428630)
10. M. Milosevic, P. Chung, and C. Parker Androgen withdrawal in patients reduces prostate cancer hypoxia: Implications for disease progression and radiation response Cancer Res 67 2007 6022 6025 (Pubitemid 47037480)
11. S. Kumar, M. Shelley, and C. Harrison Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer Cochrane Database Syst Rev 2006 CD006019
12. M. Roach III, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911 (Pubitemid 46606377)
13. R. Alonzi, A.R. Padhani, and C. Allen Dynamic contrast enhanced MRI in prostate cancer Eur J Radiol 63 2007 335 350 (Pubitemid 47321040)
14. P.J. Hoskin, D.M. Carnell, and N.J. Taylor Hypoxia in prostate cancer: Correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations Int J Radiat Oncol Biol Phys 68 2007 1065 1071 (Pubitemid 47048571)
15. S. Chopra, W.D. Foltz, and M.F. Milosevic Comparing oxygen-sensitive MRI (BOLD R2) with oxygen electrode measurements: A pilot study in men with prostate cancer Int J Radiat Biol 85 2009 805 813
16. J.A. d'Arcy, D.J. Collins, and A.R. Padhani Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: Analysis and visualization of dynamic contrast-enhanced MR imaging data Radiographics 26 2006 621 632 (Pubitemid 43515329)
17. P.S. Tofts, G. Brix, and D.L. Buckley Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232 (Pubitemid 29463104)
18. T. Fritz-Hansen, E. Rostrup, and H.B.W. Larsson Measurement of the arterial concentration of Gd-DTPA using MRI: A step toward quantitative perfusion imaging Magn Reson Med 36 1996 225 231 (Pubitemid 26271742)
19. P.S. Tofts Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J Magn Reson Imaging 7 1997 91 101 (Pubitemid 28365643)
20. J.M. Bland, and D.G. Altman Measurement error BMJ 313 1996 744
21. J.M. Bland, and D.G. Altman Measurement error proportional to the mean BMJ 313 1996 106 (Pubitemid 26257767)
22. M. Burchardt, T. Burchardt, and M.W. Chen Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration Prostate 43 2000 184 194 (Pubitemid 30230454)
23. R.J. Stewart, D. Panigrahy, and E. Flynn Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: Evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts J Urol 165 2001 688 693 (Pubitemid 32060501)
24. R. Mazzucchelli, R. Montironi, and A. Santinelli Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients Prostate 45 2000 72 79
25. D.I. Quinn, S.M. Henshall, and R.L. Sutherland Molecular markers of prostate cancer outcome Eur J Cancer 41 2005 858 887 (Pubitemid 40461690)
26. A.R. Padhani, A.D. MacVicar, and C.J. Gapinski Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging Radiology 218 2001 365 374 (Pubitemid 32121045)
27. M. Milosevic, R. Bristow, and P. Chung Prostate cancer hypoxia correlates with poor patient outcome following treatment with radiotherapy Int J Radiat Oncol Biol Phys 60 2004 S236 S237
28. R.K. Jain, N. Safabakhsh, and A. Sckell Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor Proc Natl Acad Sci U S A 95 1998 10820 10825 (Pubitemid 28413152)
29. H.F. English, N. Kyprianou, and J.T. Isaacs Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration Prostate 15 1989 233 250 (Pubitemid 20027412)
30. A. Pollack, D.L. Joon, and C.S. Wu Quiescence in R3327-G rat prostate tumors after androgen ablation Cancer Res 57 1997 2493 2500 (Pubitemid 27255912)
31. P. Westin, A. Bergh, and J.E. Damber Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma Prostate 22 1993 65 74 (Pubitemid 23075495)
32. P. Westin, P. Stattin, and J.E. Damber Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors Am J Pathol 146 1995 1368 1375
33. J.P. O'Connor, A. Jackson, and G.J. Parker DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents Br J Cancer 96 2007 189 195 (Pubitemid 46160619)
34. M.O. Leach, K.M. Brindle, and J.L. Evelhoch The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: Issues and recommendations Br J Cancer 92 2005 1599 1610 (Pubitemid 40756468)
35. E.H. Oomens, G.J. van Steenbrugge, and T.H. van der Kwast Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma J Urol 145 1991 81 85
36. G.G. Steel Cell survival as a determinant of tumour response G.G. Steel, Basic clinical radiobiology 3rd ed 2002 Arnold London 52 63
37. D.L. Joon, M. Hasegawa, and C. Sikes Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation Int J Radiat Oncol Biol Phys 38 1997 1071 1077 (Pubitemid 27353688)
38. A. Pollack, N. Salem, and F. Ashoori Lack of prostate cancer radiosensitization by androgen deprivation Int J Radiat Oncol Biol Phys 51 2001 1002 1007 (Pubitemid 33026431)